Regulatory Affairs
Expert-defined terms from the Professional Certificate in Medical Device Sales course at HealthCareCourses (An LSIB brand). Free to read, free to share, paired with a professional course.
Adequate Clinical Evidence #
Adequate Clinical Evidence
Explanation #
The body of scientific information that demonstrates a medical device’s safety and performance for its intended use. It includes results from bench testing, animal studies, and human clinical trials.
Practical application #
Sales professionals use adequate clinical evidence to answer physician questions and to support marketing claims.
Challenges #
Gathering robust data can be time‑consuming, especially for novel technologies where comparable devices are scarce.
Adverse Event Reporting #
Adverse Event Reporting
Explanation #
The mandatory process of notifying regulatory authorities of any undesirable experience associated with a device that may have caused or contributed to a serious injury or death.
Practical application #
Sales reps must understand reporting timelines (e.g., 30‑day FDA requirement) to advise customers on compliance.
Challenges #
Distinguishing between reportable and non‑reportable events and maintaining accurate documentation in fast‑moving sales environments.
Aesthetic Device Classification #
Aesthetic Device Classification
Explanation #
Classification of devices used for cosmetic purposes based on intended use and risk profile. In the U.S., many aesthetic devices fall under Class II, requiring a 510(k) submission.
Practical application #
Knowing the classification helps sales teams set realistic expectations for market entry timelines.
Challenges #
Some devices blur therapeutic and aesthetic lines, leading to regulatory ambiguity.
Audit Trail #
Audit Trail
Explanation #
A secure, time‑stamped record that shows the creation, modification, and deletion of electronic records. Required by standards such as ISO 13485 and FDA 21 CFR 820.
Practical application #
Demonstrates compliance during regulatory inspections and supports internal investigations.
Challenges #
Implementing automated audit trails without disrupting user workflow can be technically complex.
Biocompatibility Testing #
Biocompatibility Testing
Explanation #
Laboratory evaluation of a device’s interaction with biological tissues to ensure it does not cause harmful effects. Includes tests for cytotoxicity, irritation, sensitization, and systemic toxicity.
Practical application #
Results are incorporated into the device’s technical file and referenced in marketing collateral.
Challenges #
Selecting the appropriate test series for combination products and interpreting results for novel materials.
CE Mark #
CE Mark
Explanation #
A symbol indicating that a medical device complies with the relevant EU directives or regulations (e.g., MDR 2017/745) and may be marketed throughout the European Economic Area.
Practical application #
Sales teams leverage the CE Mark to assure customers of conformity with European safety standards.
Challenges #
Maintaining the CE Mark after the transition from the Medical Device Directive (MDD) to the MDR, including ongoing post‑market surveillance obligations.
Class I Device #
Class I Device
Explanation #
Devices with low to moderate risk that are subject to the least regulatory control. In the U.S., most Class I devices are exempt from premarket notification but must adhere to general controls.
Practical application #
Faster market entry allows sales teams to focus on building market share quickly.
Challenges #
Even low‑risk devices must maintain a compliant QMS; failure to do so can result in enforcement actions.
Class II Device #
Class II Device
Explanation #
Devices that pose moderate risk and typically require a premarket notification (510(k)) demonstrating substantial equivalence to a legally marketed device.
Practical application #
Sales reps must be familiar with the 510(k) clearance date to position the product as “FDA‑cleared.”
Challenges #
Demonstrating substantial equivalence can be difficult for innovative devices lacking a clear predicate.
Class III Device #
Class III Device
Explanation #
High‑risk devices that require a PMA, which involves a thorough review of clinical data, manufacturing processes, and labeling.
Practical application #
Sales cycles for Class III devices are longer; reps must manage expectations and provide detailed regulatory updates to customers.
Challenges #
The PMA pathway is costly and time‑intensive, often requiring extensive post‑approval studies.
Clinical Evaluation Report (CER) #
Clinical Evaluation Report (CER)
Explanation #
A comprehensive analysis of clinical data supporting a device’s safety and performance, required for CE Mark conformity. The CER must be updated periodically.
Practical application #
Sales teams use the CER to answer clinician inquiries about real‑world evidence.
Challenges #
Maintaining up‑to‑date CERs across multiple jurisdictions can strain resources.
Clinical Investigation #
Clinical Investigation
Explanation #
A systematic study involving human subjects designed to collect data on a device’s safety and efficacy. In the U.S., an IDE is required before a clinical investigation can begin.
Practical application #
Results feed into regulatory submissions and are often highlighted in sales presentations.
Challenges #
Recruiting participants, adhering to Good Clinical Practice (GCP) standards, and managing timelines.
Clinical Investigation Plan (CIP) #
Clinical Investigation Plan (CIP)
Explanation #
A document outlining the objectives, design, methodology, and statistical considerations of a clinical investigation. It serves as a roadmap for investigators and regulators.
Practical application #
Provides sales leadership with milestones for product launch planning.
Challenges #
Aligning the CIP with both regulatory expectations and commercial objectives.
Clinical Trial Application (CTA) #
Clinical Trial Application (CTA)
Explanation #
The dossier submitted to a national authority (e.g., Health Canada, MHRA) to obtain approval to conduct a clinical trial. It includes the protocol, investigator brochure, and informed consent forms.
Practical application #
Delays in CTA approval can push back product launch dates, affecting sales forecasts.
Challenges #
Navigating differing requirements across countries.
Clinical Trial Notification (CTN) #
Clinical Trial Notification (CTN)
Explanation #
In the U.S., a CTN is a brief notification to the FDA that a clinical investigation will be conducted under the “non‑significant risk” (NSR) category, which does not require a full IDE.
Practical application #
Allows quicker initiation of early‑stage studies, giving sales teams early data to share.
Challenges #
Ensuring the device truly meets NSR criteria to avoid regulatory penalties.
Clinical Trial Registration #
Clinical Trial Registration
Explanation #
The act of publicly posting trial details (objectives, design, status) in a recognized registry before enrollment begins. Required by many regulators for ethical and transparency reasons.
Practical application #
Demonstrates commitment to scientific openness, enhancing credibility with customers.
Challenges #
Maintaining accurate updates throughout the trial lifecycle.
Comparator Device #
Comparator Device
Explanation #
An existing legally marketed device used as a reference point in a 510(k) submission to demonstrate that the new device is at least as safe and effective.
Practical application #
Sales teams often highlight the comparator to illustrate similarity and ease of adoption.
Challenges #
Finding an appropriate comparator for novel technologies can be difficult.
Conformity Assessment #
Conformity Assessment
Explanation #
The process by which a manufacturer demonstrates that a device meets applicable regulatory requirements. In the EU, this involves a Notified Body reviewing the technical file.
Practical application #
Successful assessment enables marketing across the EEA, expanding the sales territory.
Challenges #
Coordinating documentation and audits across multiple product lines.
Controlled Device #
Controlled Device
Explanation #
A device subject to additional controls due to its high risk, special use, or potential for misuse (e.g., implantable cardioverter‑defibrillators).
Practical application #
Sales reps must educate customers on tracking and reporting obligations.
Challenges #
Managing inventory and ensuring compliance with device‑tracking regulations.
Design History File (DHF) #
Design History File (DHF)
Explanation #
A collection of records that demonstrate the design process and how design requirements were met. Required by FDA 21 CFR 820.30 and referenced in ISO 13485.
Practical application #
Provides evidence of due diligence during audits and can be leveraged in sales training to illustrate product robustness.
Challenges #
Keeping the DHF current as design changes occur.
Design Controls #
Design Controls
Explanation #
Systematic processes required by FDA regulations to ensure that a device is designed to meet user needs and intended uses. Includes stages such as design planning, input, output, review, verification, validation, and transfer.
Practical application #
Demonstrates to customers that the product underwent rigorous development, supporting premium pricing.
Challenges #
Integrating design controls with agile development methodologies.
Design Input #
Design Input
Explanation #
The documented requirements that a device must meet, derived from user needs, regulatory requirements, and risk assessments.
Practical application #
Sales teams reference design inputs to explain why certain features were included.
Challenges #
Translating vague market feedback into precise, testable specifications.
Design Output #
Design Output
Explanation #
The tangible results of the design process, including drawings, specifications, and software code, that meet the design inputs.
Practical application #
Outputs are used to create marketing collateral that accurately describes product capabilities.
Challenges #
Ensuring outputs remain aligned with inputs after design changes.
Design Validation #
Design Validation
Explanation #
The process of confirming that a device meets the needs of the intended users under actual or simulated use conditions. Validation typically includes clinical or simulated-use testing.
Practical application #
Validation data can be highlighted in sales pitches to demonstrate real‑world performance.
Challenges #
Conducting validation that satisfies both regulatory and commercial timelines.
Design Verification #
Design Verification
Explanation #
The process of confirming that design outputs meet design inputs, often through bench testing, inspection, or analysis.
Practical application #
Verification results are cited in technical briefings to reassure customers of product reliability.
Challenges #
Developing appropriate acceptance criteria for complex devices.
Device Identification (UDI) #
Device Identification (UDI)
Explanation #
A unique, standardized identifier assigned to each medical device, consisting of a device identifier (DI) and a production identifier (PI). Required for traceability in the U.S., EU, and many other markets.
Practical application #
Sales staff can use the UDI to quickly locate regulatory information for a specific device.
Challenges #
Implementing UDI across multiple product families and legacy devices.
Device Master Record (DMR) #
Device Master Record (DMR)
Explanation #
The compilation of all documents needed to produce a device, including specifications, drawings, and packaging instructions. Required by FDA regulations.
Practical application #
Ensures that sales promises about product specifications can be fulfilled by manufacturing.
Challenges #
Keeping the DMR synchronized with engineering changes.
Device History Record (DHR) #
Device History Record (DHR)
Explanation #
The record of the production history of a specific device unit or batch, including manufacturing dates, test results, and release sign‑offs.
Practical application #
Used in field service and recall situations to locate affected units.
Challenges #
Managing large volumes of DHR data for high‑volume products.
Device Registration #
Device Registration
Explanation #
The mandatory process of registering a manufacturer and its devices with the appropriate regulatory authority before marketing.
Practical application #
Sales teams must verify that a device is registered in each target market before initiating promotional activities.
Challenges #
Keeping registrations current as corporate structures evolve.
Device Tracking #
Device Tracking
Explanation #
The systematic monitoring of a device’s distribution chain to enable rapid identification of units in the event of a safety issue. Required for many implantable and high‑risk devices.
Practical application #
Enables sales reps to communicate quickly with customers during a recall, preserving brand trust.
Challenges #
Integrating tracking data across disparate distribution channels.
Document Control #
Document Control
Explanation #
The processes and tools used to manage the creation, review, approval, distribution, and archiving of documents. Ensures that only current, approved documents are used.
Practical application #
Guarantees that sales literature reflects the latest regulatory status.
Challenges #
Avoiding “document drift” when multiple teams edit the same file.
EU Medical Device Regulation (MDR) #
EU Medical Device Regulation (MDR)
Explanation #
The primary regulatory framework governing medical devices in the European Union, replacing the older Medical Device Directive (MDD) on 26 May 2021. Introduces stricter clinical evidence requirements and a new classification system.
Practical application #
Sales strategies must account for longer approval timelines and increased post‑market obligations under the MDR.
Challenges #
Updating legacy devices to meet MDR requirements and maintaining compliance across all EU member states.
European Notified Body (NB) #
European Notified Body (NB)
Explanation #
An organization designated by an EU member state to assess the conformity of certain devices before they can be CE marked. NBs conduct audits, review technical files, and issue certificates.
Practical application #
Sales teams coordinate with NBs to schedule audits that align with launch dates.
Challenges #
Limited NB capacity can cause bottlenecks for high‑volume or high‑risk devices.
FDA 510(k) Submission #
FDA 510(k) Submission
Explanation #
The premarket notification required for most Class II devices (and some Class I devices) to demonstrate that the new device is substantially equivalent to a legally marketed device.
Practical application #
The clearance date is a powerful marketing tool, often highlighted in promotional materials.
Challenges #
Identifying an appropriate predicate and addressing any differences that may affect safety.
FDA Establishment Registration & Listing #
FDA Establishment Registration & Listing
Explanation #
The requirement for manufacturers (and their U.S. agents) to register their establishment with the FDA and list each device they intend to market.
Practical application #
Sales teams must verify that a device is listed before promoting it in the United States.
Challenges #
Maintaining accurate listings when product lines change frequently.
FDA Premarket Approval (PMA) #
FDA Premarket Approval (PMA)
Explanation #
The most stringent FDA pathway, requiring comprehensive clinical data, manufacturing information, and labeling to demonstrate safety and efficacy.
Practical application #
A PMA approval provides a strong competitive advantage and can justify premium pricing.
Challenges #
High cost, long review cycles (often 12–18 months), and the need for post‑approval studies.
FDA Post‑Market Surveillance #
FDA Post‑Market Surveillance
Explanation #
Ongoing monitoring activities required after a device is marketed, including mandatory studies for certain high‑risk devices (e.g., 522 studies).
Practical application #
Sales reps must be prepared to discuss post‑market data and potential updates to the product.
Challenges #
Allocating resources for long‑term data collection and responding to emerging safety signals.
Foreign Manufacturer Representation #
Foreign Manufacturer Representation
Explanation #
The requirement that a non‑U.S. manufacturer appoint a U.S. person to act as its liaison with the FDA, and similarly for EU representation. This person handles registration, labeling, and communication with authorities.
Practical application #
Sales teams often coordinate with the appointed representative to ensure compliance in each market.
Challenges #
Finding a reliable representative who understands both regulatory and commercial nuances.
GMP (Good Manufacturing Practice) #
GMP (Good Manufacturing Practice)
Explanation #
A set of regulations that ensure devices are consistently produced and controlled according to quality standards. GMP covers all aspects of production, from raw material sourcing to final release.
Practical application #
Demonstrating GMP compliance reassures customers of product reliability.
Challenges #
Maintaining GMP across multiple contract manufacturers and geographic locations.
GHTF (Global Harmonization Task Force) #
GHTF (Global Harmonization Task Force)
Explanation #
A former collaborative group of medical device regulators that worked to harmonize regulatory requirements worldwide. Its legacy continues in the IMDRF.
Practical application #
Understanding GHTF guidance helps sales professionals align messaging across regions.
Challenges #
Keeping up with evolving guidance as the IMDRF releases new documents.
Health Canada Medical Device License (MDL) #
Health Canada Medical Device License (MDL)
Explanation #
The authorization required to market a medical device in Canada. Devices are classified into four risk classes, each with specific licensing requirements.
Practical application #
Sales teams must be aware of MDL status to target Canadian healthcare providers.
Challenges #
Navigating different submission formats and timelines compared to U.S. or EU processes.
ISO 13485 #
ISO 13485
Explanation #
An international standard specifying requirements for a quality management system where an organization needs to demonstrate its ability to provide medical devices and related services that consistently meet customer and regulatory requirements.
Practical application #
Certification can be a selling point, especially for customers that prioritize ISO compliance.
Challenges #
Implementing and maintaining the standard across multiple product lines and sites.
ISO 14971 #
ISO 14971
Explanation #
The international standard for risk management of medical devices. It outlines a systematic process for identifying hazards, estimating risks, evaluating acceptability, and implementing controls.
Practical application #
Sales reps can reference ISO 14971‑derived risk analyses to address clinician concerns about safety.
Challenges #
Continually updating risk assessments as new information emerges post‑launch.
International Medical Device Regulators Forum (IMDRF) #
International Medical Device Regulators Forum (IMDRF)
Explanation #
A voluntary group of medical device regulators that develops and publishes guidance to promote global regulatory convergence.
Practical application #
Aligning product documentation with IMDRF guidance facilitates smoother entry into multiple markets.
Challenges #
Interpreting guidance that may be non‑binding yet influential.
Labeling Requirements #
Labeling Requirements
Explanation #
The set of rules governing what information must appear on a device’s label, packaging, and accompanying documentation. Includes mandatory statements, warnings, and symbols.
Practical application #
Accurate labeling supports sales messaging and reduces the risk of misbranding.
Challenges #
Updating labels promptly when new safety information arises.
Market Authorization #
Market Authorization
Explanation #
The formal approval granted by a regulatory authority that permits the marketing of a medical device in a specific jurisdiction.
Practical application #
Sales strategies are built around the timing of market authorizations.
Challenges #
Coordinating simultaneous authorizations across multiple regions to avoid fragmented launches.
Medical Device Reporting (MDR) #
Medical Device Reporting (MDR)
Explanation #
The FDA’s mandatory system for manufacturers, importers, and device user facilities to report device‑related deaths, serious injuries, and malfunctions.
Practical application #
Sales teams must understand MDR obligations to guide customers on reporting responsibilities.
Challenges #
Ensuring timely and accurate submission of reports, especially for devices with high incident rates.
Medical Device Single Audit Program (MDSAP) #
Medical Device Single Audit Program (MDSAP)
Explanation #
A program that allows a single regulatory audit of a medical device manufacturer’s QMS to satisfy the requirements of multiple participating regulatory authorities (U.S., Canada, Brazil, Japan, Australia).
Practical application #
Streamlines audit planning for manufacturers, reducing costs and downtime.
Challenges #
Achieving and maintaining the high standards required for MDSAP acceptance.
Minor Change #
Minor Change
Explanation #
A change that does not significantly affect the device’s safety or performance, such as minor labeling updates or material substitutions. May require a supplemental 510(k) or a notice to the regulator.
Practical application #
Sales teams can communicate minor updates without major regulatory delays.
Challenges #
Determining whether a change is truly “minor” can be subjective and may trigger a full review.
Non‑Significant Risk (NSR) Device #
Non‑Significant Risk (NSR) Device
Explanation #
A device deemed to pose low risk to subjects, allowing a clinical investigation to proceed under a Clinical Trial Notification rather than a full IDE.
Practical application #
Enables quicker initiation of early‑stage studies, providing sales with early data.
Challenges #
Accurately classifying the device to avoid regulatory enforcement.
Notified Body (NB) Audit #
Notified Body (NB) Audit
Explanation #
A systematic inspection performed by a Notified Body to verify that a manufacturer’s QMS and technical documentation meet EU requirements.
Practical application #
Successful audit results in CE marking, opening the European market.
Challenges #
Audits can be resource‑intensive and may reveal gaps requiring corrective actions.
Post‑Market Surveillance (PMS) #
Post‑Market Surveillance (PMS)
Explanation #
The systematic collection and analysis of data on a device’s performance after it has been placed on the market, aimed at detecting and addressing safety issues.
Practical application #
PMS data can be used in sales presentations to demonstrate ongoing commitment to safety.
Challenges #
Managing large data sets and translating findings into actionable improvements.
Premarket Notification (PMN) #
Premarket Notification (PMN)
Explanation #
Another term for the 510(k) submission used to notify the FDA of a device’s intent to market.
Practical application #
The PMN clearance date is often featured in promotional materials.
Challenges #
Ensuring that all substantial equivalence arguments are well‑documented.
Premarket Approval (PMA) Supplement #
Premarket Approval (PMA) Supplement
Explanation #
A submission to the FDA for modifications to a device that already has an approved PMA, such as design changes or new indications.
Practical application #
Sales teams must be aware of supplement status to manage expectations for new features.
Challenges #
Supplements can take several months to review, delaying product enhancements.
Product Development Plan (PDP) #
Product Development Plan (PDP)
Explanation #
A comprehensive document outlining the stages, timelines, resources, and regulatory pathways for bringing a medical device from concept to market.
Practical application #
Aligns sales, engineering, and regulatory teams around shared launch objectives.
Challenges #
Balancing ambitious timelines with realistic regulatory requirements.
Quality Assurance (QA) #
Quality Assurance (QA)
Explanation #
The systematic activities implemented to ensure that a product meets defined quality standards. Includes audits, inspections, and process controls.
Practical application #
QA metrics can be shared with customers to demonstrate product reliability.
Challenges #
Integrating QA processes without slowing down product development.
Quality Management System (QMS) #
Quality Management System (QMS)
Explanation #
The coordinated activities and documented procedures that direct and control an organization’s quality policies and objectives. A QMS is mandatory for medical device manufacturers.
Practical application #
A robust QMS enables faster regulatory submissions and supports sales claims of quality.
Challenges #
Maintaining QMS effectiveness across global supply chains.
Regulatory Intelligence #
Regulatory Intelligence
Explanation #
The systematic collection and analysis of information about regulatory requirements, trends, and enforcement actions that may affect a company’s products.
Practical application #
Informs product positioning, risk assessments, and sales strategies.
Challenges #
Keeping intelligence current in rapidly evolving regulatory environments.
Regulatory Strategy #
Regulatory Strategy
Explanation #
The plan that defines how a company will achieve regulatory approval for a device, including choice of submission type, target markets, and risk mitigation tactics.
Practical application #
Aligns sales launch plans with realistic approval timelines.
Challenges #
Adjusting strategy when unexpected regulatory hurdles arise.
Regulatory Submission #
Regulatory Submission
Explanation #
The package of documents, data, and evidence presented to a regulatory authority to obtain market authorization. Formats include the Common Technical Document (CTD) and electronic submissions (eCTD).
Practical application #
Timely submission is critical to meet sales launch windows.
Challenges #
Compiling complex technical data while maintaining regulatory compliance.
Risk Management File (RMF) #
Risk Management File (RMF)
Explanation #
The collection of documents that demonstrate how risks associated with a device have been identified, evaluated, and controlled throughout its lifecycle.
Practical application #
RMF excerpts can be used in sales presentations to address safety concerns.
Challenges #
Keeping the RMF current as new hazards emerge post‑launch.
Safety and Performance Requirements (SPR) #
Safety and Performance Requirements (SPR)
Explanation #
The set of criteria defined by the EU MDR that a device must meet to obtain a CE Mark. Includes requirements for design, labeling, and clinical evaluation.
Practical application #
Demonstrating compliance with SPRs strengthens market credibility.
Challenges #
Interpreting the broad language of SPRs for specific device categories.
Scope of Clearance #
Scope of Clearance
Explanation #
The specific clinical applications and patient populations for which a device has been authorized by a regulator.
Practical application #
Sales reps must stay within the approved scope to avoid off‑label promotion.
Challenges #
Expanding scope often requires additional clinical data and regulatory submissions.
Software as a Medical Device (SaMD) #
Software as a Medical Device (SaMD)
Explanation #
Software that performs medical functions without being part of a hardware device. SaMD is regulated based on risk and intended use.
Practical application #
Sales teams need to articulate both clinical benefits and regulatory status of SaMD products.
Challenges #
Rapid iteration cycles can outpace traditional regulatory review timelines.
Software Validation #
Software Validation
Explanation #
The process of confirming that software functions as intended in the intended environment, including testing of algorithms, user interface, and security.
Practical application #
Validation reports support regulatory submissions and can be referenced in technical sales discussions.
Challenges #
Documenting validation for continuous updates while remaining compliant.
Standard Operating Procedure (SOP) #
Standard Operating Procedure (SOP)
Explanation #
A written, step‑by‑step instruction to achieve uniformity of performance for a specific function. SOPs are required components of a QMS.
Practical application #
SOPs ensure consistent handling of regulatory tasks, such as adverse event reporting.
Challenges #
Keeping SOPs current as processes evolve.
Supply Chain Security #
Supply Chain Security
Explanation #
Measures taken to protect the integrity of the device supply chain from manufacturing through distribution, including verification of suppliers and anti‑counterfeit strategies.
Practical application #
Secure supply chains reinforce customer confidence and protect brand reputation.
Challenges #
Coordinating security protocols across multiple third‑party logistics providers.
Technical File #
Technical File
Explanation #
The complete set of documents required to demonstrate conformity with EU regulations, including design, risk analysis, clinical evaluation, and labeling.
Practical application #
The technical file is the basis for the Notified Body’s assessment.
Challenges #
Maintaining the file’s completeness when multiple product variants exist.
Third‑Party Certification #
Third‑Party Certification
Explanation #
Certification granted by an independent organization (e.g., a Notified Body) that a product meets specific standards or regulatory requirements.
Practical application #
Third‑party marks can be leveraged in marketing to differentiate from competitors.
Challenges #
Selecting reputable certifiers and managing the cost of multiple certifications.
Traceability Matrix #
Traceability Matrix
Explanation #
A tool that links each design requirement to its corresponding verification and validation activities, ensuring full coverage.
Practical application #
Demonstrates to regulators that all requirements have been addressed, reinforcing sales claims of thorough development.
Challenges #
Keeping the matrix updated as requirements evolve.
U #
S. FDA Inspection
Explanation #
An on‑site review conducted by FDA investigators to assess a manufacturer’s compliance with applicable regulations, including the QMS and device records.
Practical application #
Successful inspections reinforce credibility with customers; findings may affect sales if negative.
Challenges #
Preparing for inspections while maintaining daily operational productivity.
Unique Device Identifier (UDI) System #
Unique Device Identifier (UDI) System
Explanation #
A global system for uniquely identifying medical devices throughout their distribution and use, facilitating traceability and post‑market monitoring.
Practical application #
Enables sales teams to quickly locate regulatory information for each device batch.
Challenges #
Implementing UDI labeling on legacy products and integrating UDI data into enterprise systems.
Validation of Manufacturing Process #
Validation of Manufacturing Process
Explanation #
Demonstrating that a manufacturing process consistently produces devices meeting predetermined specifications. Includes Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ).
Practical application #
Validated processes support claims of product consistency, a key sales point for high‑volume devices.
Challenges #
Re‑qualifying processes after changes or scale‑up.
Verification & Validation (V&V) #
Verification & Validation (V&V)
Explanation #
The combined activities that ensure a device meets its design inputs (verification) and that it fulfills its intended use in a real‑world setting (validation).
Practical application #
V&V results form the backbone of regulatory submissions and are often highlighted in technical briefings.
Challenges #
Coordinating V&V activities across multidisciplinary teams and timelines.
Vigilance System #
Vigilance System
Explanation #
The organizational framework for detecting, assessing, and responding to safety issues associated with a device after it is on the market.
Practical application #
A robust vigilance system enables rapid response to incidents, preserving market confidence.
Challenges #
Integrating data from multiple sources (clinical, field, social media) into a coherent response plan.
World Health Organization (WHO) Pre‑Qualification #
World Health Organization (WHO) Pre‑Qualification
Explanation #
A voluntary assessment program that evaluates the quality, safety, and efficacy of medical devices for use in low‑ and middle‑income countries.
Practical application #
Pre‑qualification can open access to large international procurement programs, expanding sales opportunities.
Challenges #
Meeting WHO criteria, which may differ from national regulatory requirements.
Zero‑Risk Claim #
Zero‑Risk Claim
Explanation #
A statement suggesting that a device carries no risk, which is generally prohibited because all medical devices carry some degree of risk.
Practical application #
Sales scripts must avoid absolute risk language to remain compliant.
Challenges #
Crafting persuasive yet accurate messaging that emphasizes safety without over‑promising.